RetinalGenix Technologies Inc. (RTGN)
RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
RetinalGenix Technologies Inc.
OTC:RTGNHealthcare · Medical - Devices
Mkt Cap-
Float6.25M
O/S-
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$2.43M
Total Assets$21K
Free Cash Flow-$558K
Debt & Equity
Total Debt$56K
Total Equity-$2.3M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:2.5Reverse splitJun 16, 20152.5 shares → 1
Balance Sheet Details
Assets$21K
Liabilities$2.32M
Accounts Receivable$0
Accounts Payable$1.08M
Inventory$0
PP&E (Net)$4K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $639K | $954 | $100 | $51 | $0 | $0 | $0 | $0 |
| Gross Profit | -$639K | -$954 | -$100 | -$51 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $83K | $373K | $524K | $809K | $680K | $432K | $251K | $0 |
| Selling, General, and Administrative | $1.7M | $1.33M | $1.56M | $1.07M | $1.5M | $1.65M | $555K | $1K |
| Other | $0 | $2.61M | $0 | $0 | -$680K | -$432K | $0 | $0 |
| Total Operating Expenses | $1.79M | $4.32M | $2.09M | $1.88M | $1.5M | $1.65M | $806K | $1K |
| Operating Income (EBIT) | -$2.42M | -$4.32M | -$2.09M | -$1.88M | -$2.18M | -$2.08M | -$806K | -$1K |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $4K | $4K | $4K | $5K | $3K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$4K | -$4K | -$4K | -$2.04M | -$3K | -$432K | $5 | $0 |
| Income Before Tax (EBT) | -$2.43M | -$4.32M | -$2.09M | -$3.91M | -$2.18M | -$2.08M | -$806K | -$1K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2.43M | -$4.32M | -$2.09M | -$3.91M | -$2.18M | -$2.08M | -$806K | -$1K |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -0.13 | -0.24 | -0.12 | -0.25 | -0.15 | -0.05 | -0.02 | -0.00 |
| Diluted EPS | -0.13 | -0.24 | -0.12 | -0.25 | -0.15 | -0.05 | -0.02 | -0.00 |
| Weighted Average OS | 18.56M | 17.94M | 17.35M | 15.58M | 14.28M | 39.70M | 35.15M | 27.00M |
| EBITDA | -$2.42M | -$4.32M | -$2.09M | -$3.91M | $0 | $0 | $0 | $0 |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $15K | $6K | $0 | $38 | $5K | $2K | $54K | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $15K | $6K | $0 | $38 | $5K | $2K | $54K | $0 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $15K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $44K | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 | $59 | $0 | $0 |
| Total Current Assets | $15K | $6K | $0 | $38 | $5K | $61K | $54K | $0 |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $4K | $7K | $156 | $256 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $150K | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $2K | -$148K | $0 | $0 | $0 | $44K | $0 | $0 |
| Total Long-Term Assets | $6K | $9K | $156 | $256 | $0 | $44K | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | -$44K | $0 | $0 |
| Total Assets | $21K | $15K | $156 | $294 | $5K | $61K | $54K | $0 |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $1.08M | $922K | $885K | $475K | $251K | $141K | $5K | $0 |
| Short-Term Debt | $49K | $49K | $507K | $49K | $73K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $484K | $3K | $537 | $143K | $0 | $25K | $0 |
| Total Current Liabilities | $2K | $1.47M | $1K | $1K | $470K | $141K | $30K | $0 |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $4K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $1K | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $4K | $7K | $1K | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | -$1.36M | -$1.02M | -$324K | $0 | $0 | $0 |
| Total Liabilities | $2.32M | $1.48M | $1.41M | $1.07M | $470K | $141K | $30K | $0 |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $300 | $300 | $300 |
| Common Stock | $2K | $2K | $2K | $2K | $1K | $4K | $4K | $3K |
| Retained Earnings | -$17.86M | -$15.43M | -$11.11M | -$9.02M | -$5.1M | -$2.93M | -$847K | -$3K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | -$300 | -$300 | -$300 |
| Other Stockholders' Equity | $15.55M | $13.97M | $9.7M | $7.95M | $4.64M | $2.84M | $867K | $0 |
| Total Equity | -$2.3M | -$1.46M | -$1.41M | -$1.07M | -$465K | -$80K | $24K | -$284 |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $21K | $15K | $156 | $294 | $5K | $61K | $54K | -$284 |
| Supplementary Data | ||||||||
| Total Debt | $56K | $57K | $507K | $49K | $73K | $0 | $0 | $0 |
| Net Debt | $41K | $50K | $507 | $49 | $68K | -$2K | -$54K | $0 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$2.43M | -$4.32M | -$2.09M | -$3.91M | -$2.18M | -$2.08M | -$806K | -$1K |
| Depreciation & Amortization | $3K | $954 | $100 | $51 | $2.18M | $2.08M | $806K | $1K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $1.04M | $2.61M | $664K | $259K | $308K | $220K | $28K | $929 |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $163K | $187K | $409K | $225K | $110K | $136K | $5K | $0 |
| Other Working Capital | $3K | $2K | $4K | $5K | $46K | -$44K | $0 | $0 |
| Total Working Capital Change | $166K | $189K | $4K | $230K | $156K | $92K | $5K | $0 |
| Other Non-Cash Items | $662K | $779K | $1.07M | $3.23M | -$1.63M | -$1.73M | -$190K | -$929 |
| Net Cash from Operating | -$558K | -$742K | -$348K | -$199K | -$1.17M | -$1.42M | -$157K | $0 |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $0 | -$307 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | -$307 | $0 | $0 | $0 | $0 |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $150K | $503K | $1.09M | $61K | $1.08M | $1.4M | $186K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $567K | $245K | $348K | $134K | $14K | -$25K | $211K | $0 |
| Net Cash from Financing | $567K | $748K | $348K | $195K | $1.17M | $1.37M | $211K | $0 |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $9K | $6K | -$38 | -$5K | $3K | -$52K | $54K | $0 |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$558K | -$742K | -$348K | -$199K | -$1.17M | -$1.42M | -$157K | $0 |
| Capital Expenditure | $0 | -$4 | $0 | -$307 | $0 | $3 | $0 | $0 |
| Free Cash Flow | -$558K | -$742K | -$348K | -$200K | -$1.17M | -$1.42M | -$157K | $0 |
| Cash at Beginning | $6K | $0 | $38 | $5K | $2K | $54K | $0 | $0 |
| Cash at End | $15K | $6K | $0 | $38 | $5K | $2K | $54K | $0 |